Skip to main content

Vaxxinity, Inc.

VAXXDelisted Apr 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001851657

Vaxxinity, Inc. was delisted on Apr 29, 2024; its insiders filed their last Form 4 on Apr 29, 2024; 58 institutions reported holding it in 13F filings for Q1 2024, worth $8.73M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Vaxxinity, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of VAXX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders5053+3
Shares28.5M27.7M−768.7K (−2.7%)
Value$71.7M$35.8M−$35.9M (−50.1%)

New holders (8)

Institutions that held Vaxxinity, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to VAXX in Q3 2023
InstitutionSharesValue% of portfolio
Clarius Group, LLC20,000$27.4K0.00%
Wedbush Securities Inc20,000$27.0K0.00%
Integrated Wealth Concepts LLC11,000$15.1K0.00%
SG Americas Securities, LLC10,140$14.0K0.00%
Quantum Financial Advisors, LLC10,121$13.9K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC2,050$2.81K0.00%
Deutsche Bank AG1,012$1.39K0.00%
Eagle Bay Advisors LLC32$440.00%

Sold out (5)

Institutions that held Vaxxinity, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of VAXX in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Voya Investment Management LLC18,742$47.2K
Millennium Management LLC14,012$35.3K
Susquehanna International Group, LLP12,411$31.3K
Spire Wealth Management1,500$3.78K
Venturi Wealth Management, LLC45$114